Paper
0
PIKfyve, a Class III PI Kinase, Is the Target of the Small Molecular IL-12/IL-23 Inhibitor Apilimod and a Player in Toll-like Receptor Signaling
Authors
Xinming Cai,YongYao Xu
Atwood Cheung,Ronald Tomlinson,Abel Alcázar-Román,Leon Murphy,Andreas Billich,Bailin Zhang,Yan Feng,Martin Klumpp,Jean‐Michel Rondeau,Aleem Fazal,Christopher Wilson,Vic Myer,Gérard Joberty,Tewis Bouwmeester,Mark Labow,Peter Finan,Jeffrey Porter,Hidde Ploegh,Daniel Baird,Pietro Camilli,John Tallarico
+21 authors
,Qian HuangJournal
Published
Jul 1, 2013
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.